Loading…
Docking, characterization and investigation of β-cyclodextrin complexed with farnesol, an acyclic sesquiterpene alcohol, produces orofacial antinociceptive profile in experimental protocols
[Display omitted] •β-cyclodextrin was used to obtain an inclusion complex with farnesol.•The slurry complexation method exhibited a better complexation profile.•Farnesol and βCD/FAR have an effect of reducing orofacial pain.•Possible mechanisms of action farnesol are mediated by K+ATP channels and 5...
Saved in:
Published in: | Process biochemistry (1991) 2017-11, Vol.62, p.193-204 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | [Display omitted]
•β-cyclodextrin was used to obtain an inclusion complex with farnesol.•The slurry complexation method exhibited a better complexation profile.•Farnesol and βCD/FAR have an effect of reducing orofacial pain.•Possible mechanisms of action farnesol are mediated by K+ATP channels and 5-HT3 receptors.
In this study, an inclusion complex with β-cyclodextrin and farnesol (βCD/FAR) was used to improve the physico-chemical and pharmacological properties of farnesol. The samples were obtained using the physical mixture, paste and slurry complexation methods and characterized by variety of methods. To evaluate the pharmacological effect, an animal model of orofacial pain induced by formalin, glutamate and capsaicin was used, and its possible mechanisms of action were evaluated. The slurry complexation method was produced with a formation energy of 3.45kcal/mol and exhibited a better complexation profile as it presented smaller, deformed crystals compared to the other methods, with a stable complex formed. The formation energy was 3.45kcal/mol. In the orofacial pain test induced by formalin, capsaicin and glutamate the results show that farnesol and its complex at doses of 50 and 100mg/kg significantly decreased (p |
---|---|
ISSN: | 1359-5113 1873-3298 |
DOI: | 10.1016/j.procbio.2017.07.022 |